ecg gate /sup 18 f fdg positron emission tomography single test evaluation 
	 segmental metabolism function contractile reserve patient 
	 coronary artery disease regional dysfunction 
 /sup 18 f fluorodeoxyglucose /sup 18 f fdg)-positron emission tomography pet 
	 provide information myocardial glucose metabolism diagnose 
	 myocardial viability additional information functional 
	 status necessary comparison tomographic metabolic pet datum 
	 imaging technique hamper transfer 
	 uncertainty scatter want evaluate new fourier base 
	 ecg gate pet technique use high resolution scanner provide 
	 metabolic functional datum respect feasibility patient 
	 diseased left ventricle patient coronary artery 
	 disease leave ventricular segment severe 
	 hypokinesis akinesis biplane cineventriculography include 
	 new fourier base ecg gate metabolic /sup 18 f fdg pet perform 
	 patient function rest /sup 18 f fdg uptake 
	 examine pet study use 36 segment model segmental 
	 comparison ventriculography reveal high reliability 
	 identify dysfunctional segment 96 /sup 18 f fdg uptake 
	 normokinetic hypokinetic akinetic segment 75.4+or-7.5 
	 65.3+or-10.5 35.9+or-15.2 p<0.001 segment or=70 
	 /sup 18 f fdg uptake akinesia observe residual function 
	 find 40 /sup 18 f fdg uptake additional dobutamine test 
	 perform reveal inotropic reserve viability 42 akinetic 
	 segment 45 hypokinetic segment ecg gate metabolic pet 
	 pixel base fourier smoothing provide reliable datum regional 
	 function assessment metabolism function complete 
	 judgement segmental status feasible single study 
	 transfer artefact test test variability result 
	 indicate presence considerable viable myocardium 
	 region uptake 40 50 /sup 18 f fdg 
